Raymond A. Smego
Research Subjects
Raymond A. Smego has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
D Orlovic
Sizwe Tropical Diseases Hospital, University of the Witwatersrand/South African Institute for Medical Research, Johannesburg
1 shared publicationDragana Orlovic
Sizwe Tropical Diseases Hospital, University of the Witwatersrand/South African Institute for Medical Research, Johannesburg, South Africa
1 shared publicationRanmini Kularatne
Department of Clinical Microbiology and Infectious Diseases, University of the Witwatersrand/South African Institute for Medical Research, Johannesburg, South Africa
1 shared publicationVivian Ferraz
Department of Clinical Microbiology and Infectious Diseases, University of the Witwatersrand/South African Institute for Medical Research, Johannesburg, South Africa
1 shared publication
Latest Publications
- 1 April 2001
- Vol. 5 (4) , 370-5
Paradoxical tuberculous reactions in HIV-infected patients.
To report the occurrence of paradoxical tuberculous reactions in two patients co-infected with HIV/AIDS, and to review the literature on this subject. Two HIV-infected patients with miliary tuberculosis who developed expansion of tuberculous disease at a new site following initiation of anti-tuberculosis treatment, with or without antiretroviral treatment, and an additional 29 literature cases of HIV infection with paradoxical tuberculous reaction. Index episodes of tuberculosis included pulmonary, nodal, cutaneous and miliary forms. Types of paradoxical reactions included enlargement of lymph nodes or appearance of new lymphadenopathy, radiographic worsening of pulmonary infiltrates or appearance of miliary infiltrates or pleural effusions, peritonitis, tenosynovitis, worsening or development of new soft tissue lesions, and appearance of new contrast-enhancing intracranial tuberculomas. The occurrence of paradoxical reactions appears more temporally related to antiretroviral than to anti-tuberculosis therapy. It is important for clinicians to recognise paradoxical tuberculous reactions as inflammatory responses to treatment, and to understand that they do not necessarily indicate drug resistance or an inadequate response to therapy. Anti-tuberculosis and antiretroviral drug regimens need not be altered or discontinued, although a short course of corticosteroids may be useful in reducing inflammation.
- 1 April 2001
- Vol. 5 (4) , 370-5
Paradoxical tuberculous reactions in HIV-infected patients.
To report the occurrence of paradoxical tuberculous reactions in two patients co-infected with HIV/AIDS, and to review the literature on this subject. Two HIV-infected patients with miliary tuberculosis who developed expansion of tuberculous disease at a new site following initiation of anti-tuberculosis treatment, with or without antiretroviral treatment, and an additional 29 literature cases of HIV infection with paradoxical tuberculous reaction. Index episodes of tuberculosis included pulmonary, nodal, cutaneous and miliary forms. Types of paradoxical reactions included enlargement of lymph nodes or appearance of new lymphadenopathy, radiographic worsening of pulmonary infiltrates or appearance of miliary infiltrates or pleural effusions, peritonitis, tenosynovitis, worsening or development of new soft tissue lesions, and appearance of new contrast-enhancing intracranial tuberculomas. The occurrence of paradoxical reactions appears more temporally related to antiretroviral than to anti-tuberculosis therapy. It is important for clinicians to recognise paradoxical tuberculous reactions as inflammatory responses to treatment, and to understand that they do not necessarily indicate drug resistance or an inadequate response to therapy. Anti-tuberculosis and antiretroviral drug regimens need not be altered or discontinued, although a short course of corticosteroids may be useful in reducing inflammation.
- Open Access
- 15 January 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (2) , 289-294
Dual Pulmonary Infection with Mycobacterium tuberculosis and Pneumocystis carinii in Patients Infected with Human Immunodeficiency Virus
During a 22-month period, we identified 39 patients with human immunodeficiency virus (HIV) infection (mean CD4+ count, 90 cells/mm3) who were hospit
- 15 January 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (2) , 289-294
Open AccessDual Pulmonary Infection with Mycobacterium tuberculosis and Pneumocystis carinii in Patients Infected with Human Immunodeficiency Virus
During a 22-month period, we identified 39 patients with human immunodeficiency virus (HIV) infection (mean CD4+ count, 90 cells/mm3) who were hospit
- 1 January 2001
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 5 (1) , 56-58
International work: something for everyone.
- 1 January 2001
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 5 (1) , 56-58
International work: something for everyone.